ANNA HARP: Open Payments
NPI 1235844168 · MOREHEAD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,168 in 104 payments from 22 companies in 2025. Trend: 2023 $200 · 2024 $1,017 · 2025 $2,168
Food & beverage: $2,168
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $582 |
| Madrigal Pharmaceuticals | 17 | $320 |
| Janssen Biotech, Inc. | 6 | $195 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $164 |
| Lilly USA, LLC | 8 | $142 |
| Grifols USA, LLC | 6 | $119 |
| Phathom Pharmaceuticals, Inc. | 11 | $93 |
| Ardelyx, Inc. | 4 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $73 |
| Braintree Laboratories, Inc. | 3 | $65 |
Products named: REZDIFFRA, RINVOQ, TREMFYA, MAVYRET, XIFAXAN, OMVOH, Prolastin-C Liquid, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
